Loading clinical trials...
Loading clinical trials...
The main objectives are: (i) to identify candidate fibrotic cellular pathways in UC patients treated with a JAK inhibitor filgotinib), and (ii) to detect and monitor in vivo fibrosis in UC patients us...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
NCT07374471 · Ulcerative Colitis (UC)
NCT07271069 · Ulcerative Colitis (UC)
NCT07442045 · Ulcerative Colitis (UC)
NCT07245394 · Inflammatory Bowel Disease (IBD), Crohn Disease (CD), and more
NCT07385131 · Inflammatory Bowel Disease (IBD), CD - Crohn's Disease, and more
Amsterdam UMC
Amsterdam, North Holland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions